Quality assurance for nanomaterial inhalation toxicity testing.

Area of Science:

• Inhalation Toxicology
• Nanomaterial Safety Assessment
• Good Laboratory Practice (GLP)

Background:

• Recent revisions to OECD test guidelines 412 and 413 introduce new requirements for inhalation toxicology studies.
• These revisions apply to nanomaterials (soluble and insoluble) and conventional chemicals, impacting GLP compliance.
• GLP has been infrequently applied to nanomaterial inhalation studies, creating implementation challenges.

Purpose of the Study:

• To examine key elements of GLP-compliant nanomaterial inhalation testing under revised OECD guidelines.
• To propose an alternative to increased animal numbers, considering animal welfare and scientific validity.
• To discuss limitations in toxicokinetic estimation within the new testing framework.

Main Methods:

• Review of revised OECD inhalation toxicology test guidelines (412, 413).
• Analysis of challenges in applying GLP to nanomaterial physicochemical characterization and aerosolization.
• Examination of proposed additional assays (BAL fluid, lung burden) and their implications.

Main Results:

• Revised guidelines necessitate enhanced GLP measures for nanomaterial characterization and aerosolization.
• Increased animal numbers may be required, raising animal welfare concerns.
• Current toxicokinetic estimation methods may be limited by the revised guidelines.

Conclusions:

• Implementing revised OECD guidelines for nanomaterial inhalation studies requires careful consideration of GLP, particularly for QA.
• Alternative approaches to animal testing should be explored to balance scientific rigor and animal welfare.
• Further research is needed to refine toxicokinetic estimations under the new guidelines.